Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis

Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2012-04, Vol.35 (8), p.957-958
Hauptverfasser: Halpin, S., Hamlin, P. J.
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies, Monoclonal - administration & dosage
Colitis, Ulcerative - drug therapy
Female
Gastrointestinal Agents - administration & dosage
Humans
Male
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 958
container_issue 8
container_start_page 957
container_title Alimentary pharmacology & therapeutics
container_volume 35
creator Halpin, S.
Hamlin, P. J.
description
doi_str_mv 10.1111/j.1365-2036.2012.05034.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_940834848</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>940834848</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4564-2032fb67e32fbd17e51c1b299a86de3a689da24fea8c9027174b601b95ae68893</originalsourceid><addsrcrecordid>eNqNkEtv1DAUhS0EokPhLyDvWCX4FcdBYlGNaIs04iEKRWJhOc6N5MEZt7YDM_-emCmzxpt7ZJ9zfe-HEKakpst5va0pl03FCJc1I5TVpCFc1PtHaHV6eIxWhMmuYoryM_QspS0hRLaEPUVnjAkuF88K_ViHaYJdNvHwBoc52zBBwmbMEDEka7zJLuxwGLHbjd7t3WT6ReIpDBBNBn_Axmb3C_Dsbbkp0gbvskvP0ZPR-AQvHuo5-nr57mZ9XW0-Xr1fX2wqKxopyrBs7GULpQy0hYZa2rOuM0oOwI1U3WCYGMEo2xHW0lb0ktC-awxIpTp-jl4d-97FcD9DynpyyYL3ZgdhTroTRHGhhFqc6ui0MaQUYdR3cdkoHjQlupDVW10A6gJQF7L6L1m9X6IvHz6Z-wmGU_AfysXw9mj47Twc_ruxvvh0U9SSr455lzLsT3kTf2rZ8rbRtx-u9PfNt8-Xt1-IvuZ_AJEJl2I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>940834848</pqid></control><display><type>article</type><title>Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>Halpin, S. ; Hamlin, P. J.</creator><creatorcontrib>Halpin, S. ; Hamlin, P. J.</creatorcontrib><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/j.1365-2036.2012.05034.x</identifier><identifier>PMID: 22436036</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Antibodies, Monoclonal - administration &amp; dosage ; Colitis, Ulcerative - drug therapy ; Female ; Gastrointestinal Agents - administration &amp; dosage ; Humans ; Male</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2012-04, Vol.35 (8), p.957-958</ispartof><rights>2012 Blackwell Publishing Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4564-2032fb67e32fbd17e51c1b299a86de3a689da24fea8c9027174b601b95ae68893</citedby><cites>FETCH-LOGICAL-c4564-2032fb67e32fbd17e51c1b299a86de3a689da24fea8c9027174b601b95ae68893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2036.2012.05034.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2036.2012.05034.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27903,27904,45553,45554,46388,46812</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22436036$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Halpin, S.</creatorcontrib><creatorcontrib>Hamlin, P. J.</creatorcontrib><title>Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><subject>Antibodies, Monoclonal - administration &amp; dosage</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Female</subject><subject>Gastrointestinal Agents - administration &amp; dosage</subject><subject>Humans</subject><subject>Male</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEtv1DAUhS0EokPhLyDvWCX4FcdBYlGNaIs04iEKRWJhOc6N5MEZt7YDM_-emCmzxpt7ZJ9zfe-HEKakpst5va0pl03FCJc1I5TVpCFc1PtHaHV6eIxWhMmuYoryM_QspS0hRLaEPUVnjAkuF88K_ViHaYJdNvHwBoc52zBBwmbMEDEka7zJLuxwGLHbjd7t3WT6ReIpDBBNBn_Axmb3C_Dsbbkp0gbvskvP0ZPR-AQvHuo5-nr57mZ9XW0-Xr1fX2wqKxopyrBs7GULpQy0hYZa2rOuM0oOwI1U3WCYGMEo2xHW0lb0ktC-awxIpTp-jl4d-97FcD9DynpyyYL3ZgdhTroTRHGhhFqc6ui0MaQUYdR3cdkoHjQlupDVW10A6gJQF7L6L1m9X6IvHz6Z-wmGU_AfysXw9mj47Twc_ruxvvh0U9SSr455lzLsT3kTf2rZ8rbRtx-u9PfNt8-Xt1-IvuZ_AJEJl2I</recordid><startdate>201204</startdate><enddate>201204</enddate><creator>Halpin, S.</creator><creator>Hamlin, P. J.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201204</creationdate><title>Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis</title><author>Halpin, S. ; Hamlin, P. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4564-2032fb67e32fbd17e51c1b299a86de3a689da24fea8c9027174b601b95ae68893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antibodies, Monoclonal - administration &amp; dosage</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Female</topic><topic>Gastrointestinal Agents - administration &amp; dosage</topic><topic>Humans</topic><topic>Male</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Halpin, S.</creatorcontrib><creatorcontrib>Hamlin, P. J.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Halpin, S.</au><au>Hamlin, P. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2012-04</date><risdate>2012</risdate><volume>35</volume><issue>8</issue><spage>957</spage><epage>958</epage><pages>957-958</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>22436036</pmid><doi>10.1111/j.1365-2036.2012.05034.x</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (8), p.957-958
issn 0269-2813
1365-2036
language eng
recordid cdi_proquest_miscellaneous_940834848
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content
subjects Antibodies, Monoclonal - administration & dosage
Colitis, Ulcerative - drug therapy
Female
Gastrointestinal Agents - administration & dosage
Humans
Male
title Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T03%3A49%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Commentary:%20outcomes%20after%20escalation%20of%20infliximab%20in%20moderately%20active%20ulcerative%20colitis&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Halpin,%20S.&rft.date=2012-04&rft.volume=35&rft.issue=8&rft.spage=957&rft.epage=958&rft.pages=957-958&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/j.1365-2036.2012.05034.x&rft_dat=%3Cproquest_cross%3E940834848%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=940834848&rft_id=info:pmid/22436036&rfr_iscdi=true